I

INREA S.R.O. | Ostrava, Czech Republic

Research site

(Unclaimed)

Location

Ruská 99/44, Ostrava, Ostrava-město, Czech Republic

Site insights

Top conditions

Top treatments

Deucravacitinib

LY3009104

LY3471851

Baricitinib

BMS-986165

LY3841136

Eloralintide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 4 total trials

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (POETYK SLE-2)

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe System...

Active, not recruiting

Systemic Lupus Erythematosus

Drug: Deucravacitinib

Other: Placebo

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight (ENLIGHTEN-4)

The YDAN master protocol will support two independent studies, J3R-MC-YOA1 and J3R-MC-YOA2. Each study will investigate how well and safely Eloralint...

Not yet enrolling

Overweight or Obesity

Osteoarthritis

Drug: Placebo

Drug: Eloralintide

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms